Antihistamine Use in Allergic Conditions

Introduction to Allergic Conjunctivitis

Allergic conjunctivitis is a common condition that requires proper management to prevent complications, such as corneal neovascularization, scarring, ulceration, and vision loss, as noted by the American Academy of Ophthalmology 1
Patients with allergic conjunctivitis may experience minimal local complications, such as dry eye syndrome, Meibomian gland dysfunction, and allergic rhinitis, according to the American Academy of Ophthalmology 1

Dual-action topical antihistamine/mast cell stabilizers (e.g., olopatadine, epinastine, ketotifen, azelastine) are effective first-line therapy for allergic conjunctivitis, providing both immediate symptom relief and prevention of symptoms, as recommended by the American Academy of Ophthalmology and the American Academy of Allergy, Asthma, and Immunology 1, 2, 3
Specific treatment options include:
Short-term topical corticosteroids (e.g., loteprednol etabonate 0.2%) are preferred for severe symptoms unresponsive to other treatments, but should only be used under ophthalmologist supervision due to the risk of intraocular pressure elevation, as recommended by the American Academy of Ophthalmology 1, 2, 3
Topical cyclosporine and topical tacrolimus can be considered for long-term management of severe or refractory cases of allergic conjunctivitis, as suggested by the American Academy of Ophthalmology and the European Academy of Allergy and Clinical Immunology 1, 3

Cold compresses and artificial tears can be used as adjunctive therapy to epinastine, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
Preservative-free artificial tears (2-4 times daily) can dilute allergens and inflammatory mediators, providing relief for patients with allergic conjunctivitis, as recommended by the American Academy of Ophthalmology and the British Journal of Dermatology 1, 4, 2, 3
Cold compresses can reduce local pain and swelling in patients with allergic eye reactions 5
Humidifying ambient air, avoiding direct air drafts, and taking regular breaks from screen time can help reduce eye irritation and strain, as suggested by the American Academy of Ophthalmology 6

Baseline and periodic intraocular pressure measurement is recommended to evaluate for glaucoma and cataract formation in patients using topical corticosteroids 3
Follow-up visits should include interval history, visual acuity measurement, and slit-lamp biomicroscopy to monitor treatment efficacy and potential adverse effects 3
Regular follow-up is necessary based on disease severity and treatment, with schedule follow-up within 1-2 weeks for patients using topical corticosteroids, as suggested by the European Academy of Allergy and Clinical Immunology 3

Patients should be educated on the importance of maintaining proper lens hygiene, avoiding tap water for irrigation, and avoiding punctal plugs, as recommended by the American Academy of Ophthalmology and the British Association of Dermatologists 1, 7
Patients should also be advised to follow the 20-20-20 rule, take regular breaks from screen time, and position computer screens below eye level to decrease lid aperture, as suggested by the American Academy of Ophthalmology 6
Refer children with allergic conjunctivitis to an ophthalmologist in cases of visual loss, moderate or severe pain, severe purulent discharge, corneal involvement, lack of response to therapy, recurrent episodes, or suspected vernal keratoconjunctivitis or atopic keratoconjunctivitis, as recommended by the American Academy of Ophthalmology and the American Academy of Pediatrics 1, 3

Punctal plugs should be avoided as they prevent flushing of allergens and inflammatory mediators from the ocular surface 3
First-generation antihistamines should be avoided due to sedation and anticholinergic effects, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
Oral antihistamines may induce or worsen dry eye syndrome and impair the tear film's protective barrier, as noted by the American Academy of Ophthalmology and the American Academy of Allergy, Asthma, and Immunology 1, 3
Prolonged use of ocular decongestants/vasoconstrictors can cause rebound hyperemia ("conjunctivitis medicamentosa"), as warned by the American Academy of Ophthalmology and the American Academy of Allergy, Asthma, and Immunology 2
Topical ocular corticosteroids without ophthalmologist supervision can increase intraocular pressure and cataract formation, and mask infection, as noted by the American Academy of Ophthalmology and the British Association of Dermatologists 7